Patients receiving neuromuscular blocking medications as part of their anesthetic regimen should be carefully monitored to ensure the best care and outcomes, according to recent—and independently ...
UPPSALA, SE / ACCESS Newswire / October 8, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB (publ) today announced the launch of EMGINETM, a proprietary software suite for its next-generation ...
UPPSALA, SE / ACCESS Newswire / December 26, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB (publ) today announced the launch of the latest series of innovative features for its next-generation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results